22 suspended. 22 Phase 2, 11 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 22 | Suspended 22 |
| Phase 1 | 11 | Suspended 11 |
| Phase 3 | 1 | Suspended 1 |
Follow Vascular Diseases: new trials by email Literature Review of Vascular Diseases trials Research Report on Vascular Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Human Umbilical Cord Mesenchymal Stem Cell Therapy (19#iSCLife®-CI) for Cerebral Infarction Patients in Convalescent Period. Allogeneic umbilical cord mesenchymal stem cell, Aspirin Enteric-coated Tablets & Atorvastatin Calcium - Cerebral Infarction | Phase 1 / Phase 2 | Suspended | Sclnow Biotechnology Co., Ltd. | 40 | 2026-12-31 | 2026-04-23 |
| Combination Therapy (Mirdametinib and Sirolimus) for RAS Mutated Relapsed Refractory Multiple Myeloma Mirdametinib, Sirolimus - Multiple Myeloma, Relapsed and/or Refractory Multiple Myeloma (RRMM) | Phase 1 / Phase 2 | Suspended | National Cancer Institute (NCI) | 54 | 2026-11-04 | 2026-10-30 |
| External Beam Radiation Therapy in Combination With Talquetamab for the Treatment of Multiple Myeloma Patients With Extramedullary Disease Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Extramedullary Disease in Multiple Myeloma, Multiple Myeloma | Phase 1 / Phase 2 | Suspended | City of Hope Medical Center | 20 | 2025-08-29 | 2026-10-07 |
| Testing the Combination of Two Approved Drugs and One Experimental Drug in Patients With Relapsed or Refractory Multiple Myeloma Iberdomide, Belantamab Mafodotin, Dexamethasone - Recurrent Multiple Myeloma, Refractory Multiple Myeloma | Phase 1 / Phase 2 | Suspended | Alliance for Clinical Trials in Oncology | 88 | 2025-04-23 | 2026-10-02 |
| GRAViceptive NEGlect Treatment in Acute Stroke Using Targeted Cranial ELECTrotherapy Active: High-Definition transcranial Direct Current Stimulation (HD-tDCS), Sham: High-Definition transcranial Direct Current Stimulation (HD-tDCS) - Stroke | Phase 1 / Phase 2 | Suspended | University of Sao Paulo | 28 | 2025-01-03 | 2026-07-10 |
| Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Multiple Myeloma | Phase 2 | Suspended | National Cancer Institute (NCI) | 84 | 2024-08-27 | 2026-10-19 |
| Carfilzomib, Iberdomide (CC-220) and Dexamethasone (KID) in Transplant Eligible Multiple Myeloma Carfilzomib, Iberdomide, Oral Dexamethasone - Multiple Myeloma | Phase 1 / Phase 2 | Suspended | Hackensack Meridian Health | 66 | 2022-05-13 | 2026-07-13 |
| Study of Compound Edaravone Injection for Treatment of Acute Ischemic Stroke Compound Edaravone Injection-Low dose, Compound Edaravone Injection-High dose, Edaravone Injection - Acute Ischemic Stroke | Phase 2 | Suspended | Nanjing Yoko Biomedical Co., Ltd. | 240 | 2021-11-15 | 2024-02-20 |
| The KHENERGYC Study Sonlicromanol, Placebo - Mitochondrial Diseases, Mitochondrial DNA tRNALeu(UUR) m.3243A<G Mutation | Phase 2 | Suspended | Khondrion BV | 24 | 2021-02-01 | 2025-01-10 |
| Antigen-specific T Cell Therapy for Patients With Relapsed Refractory Multiple Myeloma NEXI-002 T Cells - Relapsed Refractory Multiple Myeloma | Phase 1 / Phase 2 | Suspended | NexImmune Inc. | 9 | 2020-08-17 | 2024-01-16 |
| Short-duration Selective Brain Cooling for Patients Undergoing Mechanical Thrombectomy selective brain cooling by cold saline perfusion, mechanical thrombectomy - Hypothermia, Stroke, Acute | Phase 2 / Phase 3 | Suspended | Capital Medical University | 120 | 2018-02-06 | 2020-08-04 |
| A Study to Evaluate the Efficacy and Safety of TF0023 Spray on Subjects With Ischemic Strokes TF0023 - Ischemic Stroke | Phase 2 | Suspended | Techfields Inc | 225 | 2017-03-01 | 2024-01-05 |
| Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis Atorvastatin, Placebo - Nasopharyngeal Carcinoma, Radiation Therapy Complication | Phase 2 | Suspended | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 324 | 2017-01-01 | 2017-12-04 |
| Pilot Trial: the Safety and Feasibility of Losartan for Pulmonary Vein Stenosis Losartan - Pulmonary Vein Stenosis, Children | Phase 1 / Phase 2 | Suspended | The Hospital for Sick Children | 40 | 2016-05-01 | 2019-07-30 |
| Aneurysmal Subarachnoid Hemorrhage Trial RandOmizing Heparin Continuous Low-Dose IV Unfractionated Heparin Infusion - Aneurysmal Subarachnoid Hemorrhage, Neurobehavioral Manifestations | Phase 2 | Suspended | Robert F. James | 88 | 2016-04-01 | 2022-03-04 |
| Pulmonary Protection of Transcutaneous Electrical Acupoint Stimulation in Gynecologic Laparoscopic Surgery electroacupuncture - Reperfusion Injury | Phase 1 / Phase 2 | Suspended | Shengjing Hospital | 100 | 2015-03-01 | 2016-08-01 |
| Mesenchymal Stem Cell Administration in the Treatment of Coronary Graft Disease in Heart Transplant Patients Mesenchymal cell therapy - Coronary Disease, Heart Transplant | Phase 1 / Phase 2 | Suspended | Assistance Publique - Hôpitaux de Paris | 14 | 2014-01-01 | 2017-02-23 |
| Phase ⅡStudy of Pinocembrin Injection to Treat Ischemic Stroke Pinocembrin for Injection - Ischemic Stroke | Phase 2 | Suspended | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 216 | 2013-06-01 | 2016-06-20 |
| Safety and Efficacy of the Fruit-based Product OPAL A for the Treatment of Chronic Venous and Pressure Ulcers OPAL A, Placebo - Venous Ulcer, Pressure Ulcer | Phase 2 | Suspended | Phoenix Eagle Company | 30 | 2010-01-01 | 2014-10-30 |
| Phase II Combination Stem Cell Therapy for the Treatment of Severe Coronary Ischemia(CI) MESENDO, placebo - Heart Disease, Blocked Arteries | Phase 2 | Suspended | TCA Cellular Therapy | 60 | 2008-11-01 | 2014-05-09 |
Showing 20 of 22. Sign in to see all of them.
Multiple Myeloma (6) · Ischemic Stroke (3) · Coronary Disease (2) · Stroke (2) · Angina Pectoris (1) · Carcinoma, Renal Cell (1) · Carotid Stenosis (1) · Cerebral Infarction (1) · Coronary Artery Disease (1) · Heart Diseases (1) · Hypotension (1) · Hypothermia (1) · Intracranial Aneurysm (1) · Leigh Disease (1) · MELAS Syndrome (1)
Cardiovascular Diseases (22) · Brain Diseases (9) · Central Nervous System Diseases (9) · Cerebrovascular Disorders (9) · Nervous System Diseases (9) · Neoplasms (8) · Neoplasms by Histologic Type (8) · Blood Protein Disorders (6) · Hematologic Diseases (6) · Hemic and Lymphatic Diseases (6) · Hemorrhagic Disorders (6) · Hemostatic Disorders (6) · Immune System Diseases (6) · Immunoproliferative Disorders (6)
Magnetic Resonance Spectroscopy (3) · iberdomide (3) · Atorvastatin (2) · Biopsy (2) · Dexamethasone (2) · Specimen Handling (2) · 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (1) · Bulk Drugs (1) · Congresses as Topic (1) · Edaravone (1) · Electroacupuncture (1) · Heparin (1) · Image-Guided Biopsy (1) · Injections (1) · Losartan (1)
National Cancer Institute (NCI) (2) · Alliance for Clinical Trials in Oncology (1) · Assistance Publique - Hôpitaux de Paris (1) · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (1) · Capital Medical University (1) · City of Hope Medical Center (1) · Hackensack Meridian Health (1) · IRCCS San Raffaele (1) · Khondrion BV (1) · MetaPhore Pharmaceuticals (1) · Nanjing Yoko Biomedical Co., Ltd. (1) · NexImmune Inc. (1) · Phoenix Eagle Company (1) · Robert F. James (1) · Sclnow Biotechnology Co., Ltd. (1)
United States (10) · China (6) · Australia (1) · Brazil (1) · Canada (1) · France (1) · Italy (1) · Netherlands (1)
Chongxi Yu, Ph.D (1) · Christopher A Caldarone, MD (1) · Elizabeth M Hill, M.D. (1) · Gabriel P. Lasala, MD (1) · J Marc Simard, MD, PhD (1) · J Mocco, MD, MSc (1) · Junchao Zhu, doctor (1) · Kevin N Sheth, MD (1) · Kristi Jones (1) · Lei Guo, Dr (1) · Lonneke de Boer, MD (1) · Michael Woodward, FRACP (1) · Noa Biran, MD (1) · Richard Isnard, MD, PhD (1) · Robert F James, MD (1)
PMID 16990385, PMID 31885697, PMID 35477351
2023 (1), P30CA033572 (1), U10CA180821 (1)